While DMT acts at 5-HT2A receptors as agonist, it is also a Sig-1r agonist and has been proven to have potent protective effects against hypoxia and cerebral ischemia by activating Sig-1r [17, 19, 20]. The gene discussed is SIGMAR1; the disease is Cerebral ischemia.